Font Size: a A A
Keyword [GIST]
Result: 121 - 140 | Page: 7 of 8
121. The Role And Mechanism Of PENK Expression In Gastrointestinal Stromal Tumor
122. Comparative Analysis Of Endoscopic Full-thickness Resection And Surgical Resection Of Large Gastric Stromal Tumors
123. Photoshop-assisted Endoscopic Ultrasonography For The Identification Of Gastrointestinal Stromal Tumors And Leiomyomas
124. The Safety And Efficacy Of Endoscopic Full-thickness Resection With Over-the-scope Clip(OTSC)for Gastric Submucosal Tumors Originating From The Muscularis Propria
125. Gleevec Enhances The Radiosensitivity Of Gastrointestinal Stromal Tumor Cells By Inhibiting RAD51 Gene Expression
126. Analysis Of Clinicopathological Features And Gene Mutation On Prognosis In Patients With GIST And EGIST
127. Development And Validation Of A Prognostic Model For Gastrointestinal Stromal Tumors Patients And Analysis Of Its Clinical Utilities
128. Analysis Of Clinicopathologic And Prognostic Factors Of High Risk Extragastrointestinal Stromal Tumors
129. Antitumor Activity And Mechanism Of A Novel KIT Inhibitor Pirocitinib (PN17-1) On Gist-882 Cells
130. Synergistic Targeting Of Insulin Receptor And KIT In Imatinib-Resistant Gastrointestinal Stromal Tumors
131. Clinicopathologic Feature And Analysis Of Diagnosis And Treatment Of 115 Cases Of Gastrointestinal Stromal Tumor(GIST)
132. Study On The Anti-tumor Activity And Mechanism Of A New Generation Of Tyrosine Kinase Inhibitor PN17-1 On Drug-resistant Cells K562/G01 And GIST-1210
133. Inhibition Of Proliferation And Promotion Of Apoptosis Of GIST-T1 Cells By The Down-regulation Of C-KIT Expression
134. SHP2 Allosteric Inhibitor Batoprotafib Inhibits Proliferation Of Imatinib-resistant Gastrointestinal Stromal Tumor (GIST) And The Comprehensive Analyses Of Treatment Strategies For GIST
135. Expression Profile Analysis Of Long Non-coding RNA In Gastrointestinal Stromal Tumor And Function And Mechanism Of LncRNA-DNM3OS In Regulating Malignant Progression Of GIST
136. The Synthesis And Antitumor Activity Of Anti-DOG1 Antibody-Maytansine Diriverties Conjugates
137. Population Pharmacokinetic Analysis And Application Of Adjuvant Imatinib In The Treatment Of Gastrointestinal Stromal Tumors
138. Propensity-matched Analysis Of The Predictive Effect Of Ki67 On Postoperative Survival In Patients With Resectable Gastrointestinal Stromal Tumor
139. Detection And Significance Of AKT/mTOR/P70S6K/eIF-4E Signaling Pathway In Gastrointestinal Stromal Tumors
140. Correlation Analysis Of Risk Grade Of Gastrointestinal Stromal Tumor With Ki-67,bcl-2 And Ki-67/bcl-2
  <<First  <Prev  Next>  Last>>  Jump to